Lukens AK, Heidebrecht RW, Mulrooney C, et al. Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors. J Infect Dis. 2015;211(7):1097-103. doi:10.1093/infdis/jiu565
Sundberg TB, Xavier RJ, Schreiber SL, Shamji AF. Small-molecule control of cytokine function: new opportunities for treating immune disorders. Curr Opin Chem Biol. 2014;23:23-30. doi:10.1016/j.cbpa.2014.08.013
Hu L, Magesh S, Chen L, et al. Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction. Bioorg Med Chem Lett. 2013;23(10):3039-43. doi:10.1016/j.bmcl.2013.03.013
Gupta-Ostermann D, Wawer M, Wassermann AM, Bajorath J. Graph mining for SAR transfer series. J Chem Inf Model. 2012;52(4):935-42. doi:10.1021/ci300071y
Dimova D, Wawer M, Wassermann AM, Bajorath J. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. J Chem Inf Model. 2011;51(2):258-66. doi:10.1021/ci100477m
Watmuff B, Liu B, Karmacharya R. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder. Pharmacogenomics. 2017;18(5):471-479. doi:10.2217/pgs-2016-0187
Okoli I, Coleman JJ, Tampakakis E, et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One. 2009;4(9):e7025. doi:10.1371/journal.pone.0007025
Sharifnia T, Hong AL, Painter CA, Boehm JS. Emerging Opportunities for Target Discovery in Rare Cancers. Cell Chem Biol. 2017;24(9):1075-1091. doi:10.1016/j.chembiol.2017.08.002
Ahfeldt T, Litterman NK, Rubin LL. Studying human disease using human neurons. Brain Res. 2017;1656:40-48. doi:10.1016/j.brainres.2016.03.051
Altmann KH, Buchner J, Kessler H, et al. The state of the art of chemical biology. Chembiochem. 2009;10(1):16-29. doi:10.1002/cbic.200800758